Vikas K. Gupta

Vikas K. Gupta

Hematology

9280 W Sunset Rd
Ste 100
Las Vegas, NV 89148

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis.

Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis.

Journal: Future oncology (London, England)

Published: August 11, 2022

Showing 1-1 of 1

Last Updated: 09/26/2026